T. Rowe Price Associates »

Avadel Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $397k 30k 13.13
2024-06-30 $0 29k 0.00

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Avadel Pharmaceuticals

Henderson Group
Jeffrey L. Gendell
BlackRock
BlackRock
Vanguard Group
Braidwell
Citadel Advisors
Wealth Effects
Two Seas Capital
Vestal Point Capital
Woodline Partners
Brandes Investment Partners
Tang Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Avadel Pharmaceuticals